Sickle Cell Anemia Research Fdn Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2008 | 135,202 | 43,764 | 91,438 | 20.8 | 0% |
| 2011 | 142,240 | 138,308 | 3,932 | 8.9 | — |
| 2012 | 100,715 | 96,778 | 3,937 | 13.2 | — |
| 2013 | 81,943 | 82,563 | −620 | 15.6 | — |
| 2014 | 91,266 | 79,390 | 11,876 | 18.0 | — |
| 2015 | 63,512 | 71,840 | −8,328 | 18.5 | — |
| 2016 | 89,425 | 71,418 | 18,007 | 20.4 | — |
| 2017 | 39,587 | 41,520 | −1,933 | 34.5 | — |
| 2018 | 57,320 | 48,355 | 8,965 | 31.9 | — |
| 2019 | 96,452 | 101,317 | −4,865 | 14.6 | — |
| 2020 | 18,625 | 80,805 | −62,180 | 9.1 | — |
| 2021 | 28,409 | 61,682 | −33,273 | 5.5 | — |
| 2022 | 111,654 | 199,722 | −88,068 | 1.4 | — |
| 2023 | 237,215 | 178,978 | 58,237 | 5.4 | 46% |
In its most recent public year (2023), this organization brought in $58,237 more than it spent. Its reserves stood at about 5.4 months of spending, down from 20.8 in 2008. Staff pay was 46% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Sickle Cell Anemia Research Fdn Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works